Immunogen - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsImmunogen

Immunogen(IMGN)

ImmunoGen, Inc. (Nasdaq: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Elahere	Mirvetuximab soravtansine	2022-11-14		Fallopian tube neoplasms , Ovarian epithelial carcinoma , Peritoneal neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Mirvetuximab soravtansine

,

hereditary breast and ovarian cancer syndrome

,

,

endometrial neoplasms

,

breast neoplasms

,

triple negative breast neoplasms

,

fallopian tube diseases

,

endometrioid carcinoma

,

acinar cell carcinoma

,

neoadjuvant therapy

,

fallopian tube neoplasms

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

peritoneal neoplasms

,

urologic neoplasms

,

ovarian neoplasms

,

,

triple negative breast neoplasms

Rucaparib camsylate

urologic neoplasms

,

ovarian neoplasms

,

,

triple negative breast neoplasms

,

myeloid leukemia acute

,

,

myeloid leukemia

ANETUMAB RAVTANSINE

pancreatic neoplasms

,

,

non-small-cell lung carcinoma

,

triple negative breast neoplasms

,

cholangiocarcinoma

,

pancreatic neoplasms

,

type 2 diabetes mellitus

,

,

renal cell carcinoma

,

,

colorectal neoplasms

,

,

mantle-cell lymphoma

,

rectal neoplasms

,

,

chronic hepatitis c

,

,

brain neoplasms

,

squamous cell carcinoma of head and neck

,

cytokine release syndrome

,

neurotoxicity syndromes

,

,

large b-cell lymphoma diffuse

,

colonic neoplasms

,

kidney diseases

,

membranous glomerulonephritis

,

chronic hepatitis b

,

,

hematopoietic stem cell transplantation

,

male breast neoplasms

,

,

mouth neoplasms

,

oropharyngeal neoplasms

,

laryngeal neoplasms

,

hypopharyngeal neoplasms

,

,

b-cell chronic lymphocytic leukemia

,

non-hodgkin lymphoma

,

non-small-cell lung carcinoma

,

b-cell lymphoma

,

breast neoplasms

,

acquired immunodeficiency syndrome

,

follicular lymphoma

,

,

triple negative breast neoplasms

,

,

,

lymphoid leukemia

,

b-cell lymphoma marginal zone

,

waldenstrom macroglobulinemia

,

cystic fibrosis

,

pseudomonas infections

,

rheumatoid arthritis

,

,

,

communicable diseases

,

,

,

psoriatic arthritis

,

,

coronavirus infections

,

severe acute respiratory syndrome

,

,

coronaviridae infections

,

nidovirales infections

,

rna virus infections

,

stomach neoplasms

,

,

b-cell leukemia

CANTUZUMAB RAVTANSINE

colorectal neoplasms

,

pancreatic neoplasms

,

stomach neoplasms

,

central nervous system neoplasms

,

stomach neoplasms

,

brain neoplasms

,

medulloblastoma

,

thyroid neoplasms

,

,

,

,

endometrial neoplasms

,

renal cell carcinoma

,

,

non-hodgkin lymphoma

,

biliary tract neoplasms

,

,

prostatic neoplasms

,

ovarian epithelial carcinoma

,

pancreatic ductal carcinoma

,

,

large b-cell lymphoma diffuse

,

urologic neoplasms

,

esophageal neoplasms

,

non-muscle invasive bladder neoplasms

,

,

inflammatory breast neoplasms

,

extranodal nk-t-cell lymphoma

,

sezary syndrome

,

mycosis fungoides

,

t-cell lymphoma cutaneous

,

head and neck neoplasms

,

hodgkin disease

,

large-cell lymphoma immunoblastic

,

synovial sarcoma

,

respiratory tract diseases

,

,

respiratory tract neoplasms

,

thoracic neoplasms

,

,

squamous cell neoplasms

,

adolescent development

,

small cell carcinoma

,

b-cell lymphoma marginal zone

,

large-cell lymphoma anaplastic

,

precursor cell lymphoblastic leukemia-lymphoma

,

follicular lymphoma

,

hepatocellular carcinoma

,

liver neoplasms

,

malignant pleural effusion

,

mantle-cell lymphoma

,

b-cell lymphoma

,

kidney neoplasms

,

non-small-cell lung carcinoma

,

,

pancreatic neoplasms

,

,

neoplasm metastasis

,

colorectal neoplasms

,

ovarian neoplasms

,

urinary bladder neoplasms

,

cholangiocarcinoma

,

peritoneal neoplasms

,

fallopian tube neoplasms

,

colonic neoplasms

,

,

rectal neoplasms

,

transitional cell carcinoma

,

gallbladder neoplasms

,

female genital neoplasms

,

pelvic neoplasms

,

uterine cervical neoplasms

,

gastrointestinal neoplasms

,

unknown primary neoplasms

,

digestive system neoplasms

,

rectal diseases

,

gastrointestinal diseases

,

intestinal neoplasms

,

digestive system diseases

,

colonic diseases

,

intestinal diseases

,

breast neoplasms

LORVOTUZUMAB MERTANSINE

multiple myeloma

,

,

ovarian neoplasms

,

merkel cell carcinoma

,

plasma cell neoplasms

,

,

small cell lung carcinoma

,

,

synovial sarcoma

,

rhabdomyosarcoma

,

neurofibrosarcoma

,

,

pulmonary blastoma

,

,

hematologic neoplasms

prostatic neoplasms

,

NARATUXIMAB EMTANSINE

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

non-hodgkin lymphoma

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

prostatic neoplasms

,

prostatic neoplasms

,

1

2

3

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use